Market Size of Germany Bariatric Surgery Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 2.80 % |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Germany Bariatric Surgery Market Analysis
The German bariatric surgery market is expected to register a CAGR of 2.8% during the forecast period.
The COVID-19 pandemic impacted the healthcare systems throughout the world, including Germany. The pandemic also impacted the bariatric surgery market in Germany. People in Germany could not go to work or exercise due to the lockdown and government controls, and the additional stress caused by the pandemic contributed to obesity in the country. According to the study published in Clinical Obesity in July 2021, as a result of the COVID-19 outbreak in the Spring of 2020, 86% of bariatric procedures in Germany were cancelled. Social restrictions and the use of telemedicine, among other things, had encouraged a housebound lifestyle that was detrimental for bariatric patients. Thus, COVID-19 profoundly impacted the German bariatric surgery market. Since restrictions are removed, the market has been recovering strongly. Over the anticipated period, a rise in bariatric treatments and the reopening of clinics will drive the market's recovery.
Certain factors are propelling the growth of the market, including the increasing incidence of obesity among people, growing government initiatives to curb obesity, and the rising prevalence of type 2 diabetes and heart diseases. According to the study published in Journal of Health Monitoring in September 2022, 53. 5% of adults in Germany were overweight, with men being more obese than women. Obesity was prevalent in both sexes at 19.0%. In both men and women, the prevalene of overweight and obesity increased with age in Germany.
Additionally, in obese people insulin resistance with impairment of β-cell function led to the development of diabetes and the growing prevalence of diabetes is likely to support the growth of the market. For instance, as per the 2021 report of the International Diabetes Federation (IDF), there were about 6.2 million people in Germany with diabetes. This number is projected to reach 6.5 million by 2030 which is further expected to boost the studied market's growth over the forecast period.